Bone grafts as vancomycin carriers in local therapy of resistant infections

Folia Microbiologica

Volumn 57, Issue 5, 2012, Pages 459-462

  Melichercik P ^a   Jahoda, D ^a   Nyc O ^b   Klapkova E ^b   Bartak V ^a   Landor, I ^a   Pokorny D ^a   Judl, T ^a   Sosna, A ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DRUG CARRIER; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BONE TRANSPLANTATION; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; EVALUATION; HUMAN; METHODOLOGY; MICROBIOLOGY; OSTEOMYELITIS; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BONE TRANSPLANTATION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, BACTERIAL; HUMANS; OSTEOMYELITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 84865462216     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-011-0093-2     Document Type: Article

References (31)

1. Appelbaum PC (2007) Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 30: 398-408.
2. Bahrs C, Marschal M, Weise K, Lingenfelter E, Dietz K, Heeg P, Eingartner C (2006) Acute musculoskeletal infection: comparison of different methods for intraoperative bacterial identification. Acta Chir Orthop Traumatol Cech 73: 237.
3. Barcia-Macay M, Mouaden F, Mingeot-Leclercq MP, Tulkens PM, van Bambeke F (2008) Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts). J Antimicrob Chemother 61: 1288-1294.
4. Bert F, Leflon-Guibout V, Le Grand J, Bourdon N, Nicolas Chanoine MH (2009) Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review. Pathol Biol (Paris) 57: 56-60.
5. Boucher H, Miller GL, Ranozabler R (2010) Serious infection caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 51: 184-197.
6. Buttaro M, González Della Valle AM, Pineiro L, Mocetti E, Morandi AA, Piccaluga F (2003) Incorporation of vancomycin-supplemented bone incorporation of vancomycin-supplemented bone allografts: radiographical, histopathological and immunohistochemical study in pigs. Acta Orthop Scand 74: 505-513.
7. Campoccia D, Montanaro L, Speziale P, Arciola CR (2010) Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials 31: 6363-7637.
8. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK (2003) Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348: 1342-1347.
9. Cunha BA (2008) Vancomycin revisited: a reappraisal of clinical use. Crit Care Clin 24: 393-420.
10. Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE (1996) Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthp Relat Res 333: 245-251.
11. Faden D, Faden HS (2009) The high rate of adverse drug events in children receiving prolonged outpatient parenteral antibiotic therapy for osteomyelitis. Pediatr Infect Dis J 28: 539-541.
12. Fraimow HS (2009) Systemic antimicrobial therapy in osteomyelitis. Semin Plast Surg 23: 90-99.
13. Fridkin SK (2001) Vancomycin intermediate and resistant Staphylococcus aureus: what infectious disease specialists need to know. Clin Infect Dis 32: 429-439.
14. Gallo J, Sauer P, Dendis M, Loveckova Y, Kolar M, Zapletalova J, Janout V (2006) Molecular diagnostics for the detection of prosthetic joint infection. Acta Chir Orthop Traumatol Cech 73: 85.
15. Jahoda D, Nyc O, Pokorny D, Landor I, Sosna A (2006a) Antibiotics in the prevention of infectious complications associated with joint replacement surgeries. Acta Chir Orthop Traumatol Cech 73: 108.
16. Jahoda D, Nyc O, Pokorny D, Landor I, Sosna A (2006b) Linezolid in the treatment of resistant Gram-positive infections of the motor system. Acta Chir Orthop Traumatol Cech 73: 329.
17. Jahoda D, Nyc O, Simsa J, Kucera E, Hanek P, Chrz P, Pokorny D, Tawa N, Landor I, Sosna A (2007) The occurrence of late hematogenic infections of joint replacements in our set and a proposal for system prevention. Acta Chir Ortop Traumatol Cech 74: 397.
18. Jahoda D, Nyc O, Simsa J, Kucera E, Hanek P, Chrz P, Pokorny D, Tawa N, Landor I, Sosna A (2008a) Late hematogenic infections of joint replacements. Acta Chir Ortop Traumatol Cech 75: 88-92.
19. Jahoda D, Sosna A, Nyc O et al (2008b) Infectious complications of joint replacements. Triton, Prague.
20. Jahoda D, Pokorny D, Nyc O, Bartak V, Hrohadka R, Landor I, Sosna A (2008c) Infectious complications of total shoulder arthroplasty. Acta Chir Ortop Traumatol Cech 75: 422-428.
21. Meani E, Romano C, Crosby L, Hofmann G (2008) Infection and local treatment in orthopedic surgery. Springer, New York.
22. Melter O, Aires de Sousa M, Laskafeldova K, Urbaskova P, Wünschova M, de Lencastre H (2004) Delineation of the endemic and sporadic methicillin-resistant Staphylococcus aureus clones in a Czech hospital. Microb Drug Resist 10: 218-223.
23. Nyc O, Matejkova J (2010) Stenotrophomonas maltophilia: significant contemporary hospital pathogen-review. Folia Microbiol 55: 286-294.
24. Parvizi J, Azzam K, Ghanem E, Austin MS, Rothman RH (2009) Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Clin Orthop Relat Res 467: 1732-1739.
25. Randelli P, Evola FR, Cabitza P, Polli L, Denti M, Vaienti L (2009) Prophylactic use of antibiotic-loaded bone cement in primary total knee replacement. Knee Surg Sports Traumatol Arthrosc 18: 181-186.
26. Somerville AL, Wright DH, Rotschafer JC (1999) Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease. Pharmacother 19: 702-707.
27. von Eiff C, Peters G, Heilmann C (2002) Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2: 677-685.
28. Winkler H, Janata O, Berger C, Wein W, Georgopoulos A (2000) In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother 46: 423-428.
29. Winkler H, Stobier A, Kaudela K, Winter F, Menschik F (2008) One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg Br 90: 1580-1584.
30. Witso E, Persen L, Loseth K, Bergh K (1999) Adsorption and release of antibiotics from morselized cancellous bone. Acta Orthop Scand 70: 298-304.
31. Witso E, Persen L, Benum P, Bergh K (2005) Cortical allograft as a vehicle for antibiotic delivery. Acta Orthop Scand 76: 481-486.